Compared with this validation cohort, patients in the derivation cohort were older (69 years), had a similar prevalence of females, had a lower prevalence of hypertension (57%) but a similar prevalence of history of stroke and insulin-treated diabetes, and had a lower level of NT-proBNP (1023 pg/mL).9 The gene discussed is NPPB; the disease is stroke disorder.